Table 4.
Variable | Crude OR (95% CI) | P-value | Adjusted OR (95% CI) | P-value |
---|---|---|---|---|
WBC | ||||
OSO/1 | 1.176 (0.969–1.426) | 0.100 | 1.174 (0.947–1.456) | 0.144 |
OSO/2 | 1.191 (0.988–1.437) | 0.067 | 1.242 (0.998–1.546) | 0.052 |
OSO/3 | 1.342 (1.098–1.640) | 0.004 | 1.410 (1.111–1.789) | 0.005 |
SIRI | ||||
OSO/1 | 93.919 (18.734–470.854) | < 0.001 | 90.225 (15.146–537.469) | < 0.001 |
OSO/2 | 56.043 (11.376–276.083) | < 0.001 | 76.861 (12.668–466.326) | < 0.001 |
OSO/3 | 167.699 (32.781–857.895) | < 0.001 | 247.651 (39.090–1568.985) | < 0.001 |
AISI | ||||
OSO/1 | 1.020 (1.013–1.026) | < 0.001 | 1.018 (1.011–1.026) | < 0.001 |
OSO/2 | 1.018 (1.012–1.025) | < 0.001 | 1.018 (1.011–1.025) | < 0.001 |
OSO/3 | 1.022 (1.015–1.028) | < 0.001 | 1.021 (1.014–1.029) | < 0.001 |
NLR | ||||
OSO/1 | 25.191 (10.666–59.496) | < 0.001 | 61.909 (18.317–209.245) | < 0.001 |
OSO/2 | 25.871 (11.084–60.385) | < 0.001 | 72.926 (21.418–248.309) | < 0.001 |
OSO/3 | 54.583 (22.596–131.848) | < 0.001 | 165.623 (46.879–585.150) | < 0.001 |
PLR | ||||
OSO/1 | 1.025 (1.014–1.035) | < 0.001 | 1.026 (1.014–1.039) | < 0.001 |
OSO/2 | 1.030 (1.019–1.040) | < 0.001 | 1.029 (1.016–1.042) | < 0.001 |
OSO/3 | 1.031 (1.020–1.042) | < 0.001 | 1.030 (1.016–1.044) | < 0.001 |
LMR | ||||
OSO/1 | 0.861 (0.787–0.942) | 0.001 | 0.845 (0.771–0.927) | < 0.001 |
OSO/2 | 0.895 (0.828–0.969) | 0.006 | 0.876 (0.806–0.952) | 0.002 |
OSO/3 | 0.737 (0.652–0.834) | < 0.001 | 0.734 (0.638–0.845) | < 0.001 |
Data from the OSO/0 group were used as normal reference values and logistic regression analyses were conducted to evaluate the potential of the inflammatory indices as surrogates for the risk of disorders with abnormal body composition, with P < 0.05 considered statistically significant
Adjustment was made for sex, monthly household income, regular exercise, age, diabetes, coronary heart disease, alcohol consumption, sunlight exposure, creatinine, fatty liver disease, TG, UA, TCH, LDL, and HDL